Physician profile
Shailja Kaul
NPI 1780841270
$8,789.24
in general payments reported to CMS, 2019-2025
50 companies · $1,409 in 2025
The $1,409 reported for 2025 was more than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,075 · 2020: $825 · 2021: $1,015 · 2022: $1,330 · 2023: $1,588 · 2024: $1,548 · 2025: $1,409.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,503 · Education: $41.43.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,503.16 |
| Education | $41.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $904.30 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Amgen INC. | $900.76 | 2019-2025 | Evenity, Prolia, Tepezza |
| Astrazeneca Pharmaceuticals Lp | $847.47 | 2019-2024 | Farxiga |
| Lilly USA, LLC | $793.41 | 2019-2025 | Mounjaro, Zepbound, Trulicity |
| Mannkind Corporation | $443.39 | 2019-2025 | Afrezza |
| Corcept Therapeutics | $380.32 | 2019-2025 | Korlym |
| Sanofi-Aventis U.S. LLC | $367.61 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $362.28 | 2019-2025 | Jardiance |
| Xeris Pharmaceuticals, INC. | $343.75 | 2020-2025 | Recorlev, Gvoke Hypopen |
| Abbott Laboratories | $336.01 | 2019-2025 | Freestyle Libre 3 |
| Dexcom, INC. | $293.60 | 2019-2025 | Dexcom G6 Transmitter |
| Horizon Therapeutics Plc | $275.76 | 2020-2023 | Tepezza |
| Medtronic, INC. | $229.22 | 2021-2025 | Minimed 780g, Inpen Smart Insulin Delivery System |
| Tandem Diabetes Care, INC. | $207.68 | 2019-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Radius Health, INC. | $190.09 | 2020-2025 | Tymlos |
Show all 50 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insulet Corporation | $169.03 | 2023-2025 | Omnipod |
| Antares Pharma, INC. | $149.08 | 2021-2025 | Xyosted |
| Medtronic Minimed, INC. | $117.35 | 2019-2020 | |
| Tolmar, INC. | $111.52 | 2023-2025 | Jatenzo |
| Merck Sharp & Dohme LLC | $101.83 | 2019-2022 | |
| Kyowa Kirin, INC. | $100.27 | 2023-2025 | Crysvita |
| Bayer Healthcare Pharmaceuticals INC. | $86.19 | 2022-2025 | |
| Amarin Pharma, INC. | $75.92 | 2020-2022 | |
| Becton, Dickinson and Company | $74.77 | 2022 | |
| Madrigal Pharmaceuticals | $69.26 | 2025 | Rezdiffra |
| Beta Bionics, INC. | $68.58 | 2023-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Recordati_rare_diseases_inc. | $61.33 | 2025 | Isturisa |
| Ibsa Pharma INC. | $57.54 | 2019-2025 | Flector, Tirosint, Licart |
| Ultragenyx Pharmaceutical INC. | $56.92 | 2021-2023 | |
| Intuity Medical INC | $51.49 | 2023 | Pogo Automatic Blood Glucose Monitoring System |
| Ascensia Diabetes Care US INC. | $45.16 | 2021-2023 | |
| Abbvie INC. | $44.72 | 2019-2025 | |
| Chiesi USA, INC. | $44.23 | 2024-2025 | Myalept |
| Embecta Corp. | $42.98 | 2023 | Bd Nano 2nd Gen Pen Needle |
| Alexion Pharmaceuticals, INC. | $39.76 | 2022-2023 | Strensiq |
| Halozyme INC | $37.02 | 2023 | |
| Vistapharm, INC. | $35.69 | 2021 | |
| Amneal Pharmaceuticals LLC | $32.06 | 2019-2025 | Unithroid |
| Sun Pharmaceutical Industries INC. | $29.02 | 2020 | |
| Amryt Pharma Holdings Ltd | $28.74 | 2021-2023 | Mycapssa |
| Janssen Pharmaceuticals, INC | $26.31 | 2019-2020 | |
| Sanofi US Services INC. | $23.70 | 2024 | |
| Ipsen Biopharmaceuticals, INC | $22.05 | 2022 | |
| Ascendis Pharma Endocrinology INC | $19.74 | 2025 | Yorvipath |
| Verity Pharmaceuticals INC. | $19.59 | 2025 | Tlando |
| Sequel Med Tech, LLC | $19.30 | 2025 | Twiist |
| Cequr Corporation | $14.25 | 2023 | Cequr Simplicity |
| Clarus Therapeutics INC. | $14.24 | 2021 | |
| Valeritas, INC. | $13.72 | 2019 | |
| Vivus LLC | $10.23 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shailja Kaul listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.